Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Miles

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1996
Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamideG D MacLean, D W Miles, R D Rubens, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Activity and toxicity of carboplatin and iproplatin in relapsed high-grade gliomaC J Twelves, C M Ash, D W Miles, et al.
British Journal of Cancer|July 1, 1995
Nitric oxide synthase activity in human breast cancerL L Thomsen, D W Miles, L Happerfield, et al.
The Journal of Pathology|March 13, 1998
The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissueL C Happerfield, D W Miles, D M Barnes, et al.
British Journal of Cancer|February 24, 1998
Persistent induction of nitric oxide synthase in tumours from mice treated with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acidE Moilanen, L L Thomsen, D W Miles, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II studyJ Carmo-Pereira, F O Costa, D W Miles, et al.
Journal of the American Chemical Society|July 1, 1970
Circular dichroism of nucleoside derivatives. IX. Vicinal effects on the circular dichroism of pyrimidine nucleosidesD W Miles, W H Inskeep, M J Robins, et al.
Immunology|December 28, 1999
Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesinD Nath, A Hartnell, L Happerfield, et al.
Journal of the American Chemical Society|April 7, 1971
Circular dichroism of nucleoside derivatives. X. Influence of solvents and substituents upon the Cotton effects of guanosine derivativesD W Miles, L B Townsend, M J Robins, et al.
British Journal of Cancer|March 31, 1999
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancerS J Houston, T A Plunkett, D M Barnes, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1996
Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamideG D MacLean, D W Miles, R D Rubens, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Activity and toxicity of carboplatin and iproplatin in relapsed high-grade gliomaC J Twelves, C M Ash, D W Miles, et al.
British Journal of Cancer|July 1, 1995
Nitric oxide synthase activity in human breast cancerL L Thomsen, D W Miles, L Happerfield, et al.
The Journal of Pathology|March 13, 1998
The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissueL C Happerfield, D W Miles, D M Barnes, et al.
British Journal of Cancer|February 24, 1998
Persistent induction of nitric oxide synthase in tumours from mice treated with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acidE Moilanen, L L Thomsen, D W Miles, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II studyJ Carmo-Pereira, F O Costa, D W Miles, et al.
Journal of the American Chemical Society|July 1, 1970
Circular dichroism of nucleoside derivatives. IX. Vicinal effects on the circular dichroism of pyrimidine nucleosidesD W Miles, W H Inskeep, M J Robins, et al.
Immunology|December 28, 1999
Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesinD Nath, A Hartnell, L Happerfield, et al.
Journal of the American Chemical Society|April 7, 1971
Circular dichroism of nucleoside derivatives. X. Influence of solvents and substituents upon the Cotton effects of guanosine derivativesD W Miles, L B Townsend, M J Robins, et al.
British Journal of Cancer|March 31, 1999
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancerS J Houston, T A Plunkett, D M Barnes, et al.
Pageof 8